Depixus
Paris, France
Depixus (formerly PicoSeq) is undertaking commercial development of a disruptive new technology for the fast, accurate, and inexpensive extraction of sequence and epigenetic information from long individual molecules of DNA and RNA. Our MAGNA technology goes beyond decoding the static genetic code to reveal the dynamics of the genome that control health and disease.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2012
- Website
- depixus.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Depixus?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now